People: Aegerion Pharmaceuticals Inc (AEGR.O)

AEGR.O on Nasdaq

22.95USD
18 Dec 2014
Price Change (% chg)

-- (--)
Prev Close
$22.95
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,250,661
52-wk High
$74.57
52-wk Low
$19.10

Search Stocks

Scheer, David 

Brief Biography

Mr. David I. Scheer is Independent Chairman of the Board of Aegerion Pharmaceuticals Inc., since February 2005. Since 1981, Mr. Scheer has served as President of Scheer & Company, Inc. (a company that provides venture capital, corporate strategic and transactional advisory services in the life sciences industry). Mr. Scheer serves as the Chairman of the Boards of Directors of Tengion, Inc. (a biopharmaceutical company focused on developing neo-organs) and Achillion Pharmaceuticals, Inc. (a biopharmaceutical company focused on the treatment of infectious diseases) and as a director of several privately held companies. Mr. Scheer is also a member of the Advisory Committee to the Harvard Malaria Initiative and the Leadership Council for the Harvard School of Public Health. Mr. Scheer holds an A.B. degree from Harvard College and an M.S. degree in cell, molecular and development biology from Yale University.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

David Scheer

--

Marc Beer

7,036,540

Mark Fitzpatrick

1,888,490

Carolina Alarco

--

Craig Fraser

1,979,770

Anne Cook

2,258,030
As Of 30 Dec 2013
Search Stocks